gene expression; pregnancy DESPITE THE WIDER APPLICATION of embryo transfer technology in modern cattle breeding, several transfers end up without pregnancy establishment. This pregnancy failure has enormous economic implications by retarding genetic progress and increasing the cost of maintaining recipients.
Pregnancy failure can be attributed to incompetency of the embryo and/or inadequate lack of endometrial receptivity. Therefore, successful pregnancy is the result of coordinated and synchronized cross talk between the conceptus and the receptive endometrium in a temporal and cell specific manner (13, 24, 40, 57, 60, 70) . The endometrial receptivity is known to be affected by certain genes whose expression is induced or reduced over time. In this regard different sets of genes were reported to be expressed or suppressed during the window implantation in human (21, 22, 35, 39, 44, 52) . Thus aberrant endometrial genes expression during critical period of pregnancy establishment could result in implantation failure and infertility (61, 63) . Therefore, selecting cows having adequate endometrial receptivity and developmentally competent embryos based on the gene expression pattern may increase the number of calves born following embryo transfer. Hence, investigating the endometrial and embryonic gene expression during the time of embryo transfer and relating this information to pregnancy outcome may provide a unique opportunity to generate molecular markers that are related to endometrial receptivity and embryo implantation.
Despite enormous efforts in characterizing bovine endometrial gene expression during the estrous cycle and early pregnancy (5-7, 43, 46) , the recipient endometrial gene expression patterns during the estrous cycle and the subsequent effect on the upcoming pregnancy outcome have not been investigated. With regard to the embryo, we have previously shown the possibility of establishing a direct connection between transcript abundance of in vitro-produced bovine blastocyst biopsy and pregnancy success after transfer of embryos (17) . However, no information is available on the relationship between in vivo-produced bovine embryo transcriptome profile and pregnancy success. Thus, investigating the gene expression of the endometrium and in vivo-derived transferable embryos in relation to the pregnancy success can be useful in developing molecular markers associated with establishment of successful pregnancy. Here, using endometrium and embryo biopsy technology in conjunction with the pregnancy outcome information, we have established a direct link between the pretransfer endometrial or in vivo-derived embryo gene expression and pregnancy outcome.
MATERIALS AND METHODS
Animal handling and management. The experiment was licensed by local authorities, and animal handling and management adhered to the rules and regulations of the German law of animal protection. Fifty-four Simmental cyclic heifers were selected on the basis of general clinical examination and normal ovarian cyclicity. The animals were housed in a free-stall barn with slotted floors and cubicles lined with rubber mats, and they were fed a total mixed ration.
Endometrial biopsy collection. The design and experimental setup of the present study are shown in Fig. 1 . Prior to endometrial biopsy collection, experimental heifers were estrous synchronized by intramuscular administration of 500 mg of the prostaglandin F 2␣ (PGF2␣) analog cloprostenol (Estrumate, Munich, Germany) twice within 11 days. Two days after each of the PGF2␣ treatments, animals received 0.02 mg GnRH-analog buserelin (Receptal; Intervet, Boxmeer, the Netherlands). Two PGF2␣ treatments were performed on day 14 and 17 followed by administration of 0.02 mg GnRH at day 18 to induce ovulation. Common signs of estrus were monitored by visual observation three times per day followed by careful palpation of ovaries to check the presence of corpus luteum. Following this, endometrial biopsies were collected from experimental animals by a cytobrush technique. Cytobrush technique is a consistent and reliable method for obtaining endometrial samples for cystologic examination and gene expression analysis from dairy cows (19, 36, 37) . For collecting the endometrial samples, a brush 20 mm in length and 6 mm in diameter (Gynobrush; Heinz Herenz, Hamburg, Germany) protected by a one-way catheter was inserted via the cervix into the uterine body. Inside the uterus, the brush was pushed gently out of the catheter and rolled along the uterine wall. Thereafter, the brush was retracted into the catheter to protect it from contamination during the passage through the genital tract. For each animal, endometrial samples were collected at days 7 and 14 of the estrous cycle during the pretransfer cycle (one cycle prior to embryo transfer) and stored in RNAlater (Sigma-Aldrich, St. Louis, MO) until further use. Days 7 and 14 of the estrous cycle were chosen for two main reasons. First, most often embryo transfer in cattle is performed by using blastocyst stage embryo at day 7 of the estrous cycle (7, 30, 43, 54) or, in case of artificial insemination, most of the embryos reach the uterus and develop to the blastocyst stage at day 7 of the estrous cycle. Moreover, day 7 of the estrous cycle is marked by formation of corpus luteum. Second, in the absence of embryo in the uterus, the uterine PGF2␣ increases at day 14 of the estrous cycle leading to corpus luteum regression (56) .
Superovulation, blastocyst recovery, and embryo transfer. Presynchronization was performed by administration of 500 mg im of the PGF2␣ analog cloprostenol (Estrumate, Munich, Germany) twice within 11 days. Two days after each of the PGF 2␣ treatments, animals received 0.02 mg of GnRH-analog buserelin (Receptal; Intervet, Boxmeer, The Netherlands). Twelve days after the last GnRH injection, cows received the first of eight consecutive FSH injections over 4 days in decreasing doses. Two PGF 2␣ treatments were performed 60 and 72 h after the initial FSH. Finally, 48 h after the first PGF2␣ application, ovulation was induced by administration of 0.02 mg of buserelin, and three artificial inseminations were performed within a 12 h interval. The time of the second insemination (60 h after the first PGF 2␣ application) was defined as day 0. Blastocysts embryos were flushed 7 days after insemination by draining each uterine horn with 500 ml phosphate-buffered saline solution (PBS) using CH15 embryo-flushing catheter (Wörrlein, Ansbach, Germany) connected to an embryo filter (Immuno Systems). Good-quality blastocysts were subjected to biopsying using a beaver microblade (Minitüb, Tiefenbach, Germany) fixed to a micromanipulator under inverse microscope (Leica Camera, Solms, Germany). Following biopsying, 60 -70% portion of the blastocyst containing both inner cell mass (ICM) and trophectoderm cells (TE) was cultured in vitro in CR1 medium supplemented with amino acid for 2 h and transferred to 54 synchronized Simmental heifers. The remaining 30 -40% of the embryo biopsy containing both ICM and TE was washed twice in PBS and snap-frozen in cryo-tubes containing minimal amounts of lysis buffer [0.8% Igepal (Sigma-Aldrich), 40 U/ml RNasin (Promega), 5 mM dithiothreitol (Promega)]. All frozen embryos were stored at Ϫ80°C until RNA isolation.
Pregnancy diagnosis and endometrial and embryo biopsy categorization. Pregnancy diagnosis was performed at days 28 and 42 using ultrasonography (Pie Medical, 5 MHz) and at day 56 by rectal palpation. Those heifers returning to heat at day 21 were categorized as nonno pregnancy Fig. 1 . The overall experimental design applied in the study. Endometrial biopsies were taken at days 7 and 14 of the estrous cycle during the pretransfer period. In the next cycle blastocyst-stage embryos were transferred to Simmental heifers at day 7 of the estrous cycle after a 30 -40% part of the embryo was taken as a biopsy. Following pregnancy diagnosis at 3 different time points, the endometrial and embryo biopsies were classified according to the pregnancy outcome as calf delivery group (CD) and no pregnancy group (NP). Numbers 1 and 2 represent the transcriptome analysis between receptive and nonreceptive endometrium at days 7 and 14 of the estrous cycle, and 3 and 4 represent the transcriptome dynamic analysis of receptive and nonreceptive endometrium. pregnant (NP) or considered as receptive endometrium. Those heifers with calf deliveries were categorized as the calf delivery group (CD) or considered as receptive endometrium. At the end of gestation, the endometrial and embryo biopsies collected during the pretransfer period were classified according to the pregnancy outcome information (Fig. 1) . Those endometrial biopsies collected at days 7 and 14 of the estrous cycle from calf delivery groups (receptive endometrium) were designated as CDd7 and CDd14, respectively. Endometrial biopsies taken at days 7 and 14 of the estrous cycle from those resulting in no pregnancy (nonreceptive endometrium) were designated as NPd7 and NPd14, respectively. Similarly, the embryo biopsies were classified according to the pregnancy outcome information. Embryo biopsies taken from those blastocysts that resulted in calf delivery were considered as calf delivery group, while biopsies taken from blastocysts resulting in no pregnancy were designated as no pregnancy group (Fig. 1) .
Total RNA isolation from endometrial biopsies. Total RNA was extracted from three pools of endometrial sample from each category using RNeasy mini kit (Qiagen, Hilden, Germany) with slight modification. In brief, three pools of endometrial cytobrush samples from each group namely: CDd7, CDd14, NPd7, or NPd14 were transferred in 2 ml Eppendorf tubes filled with 500 l of RLT buffer containing 10% 14.3 M ␤-mercaptoethanol (␤-ME, Thermo Fisher Scientific). The samples were then vortexed for 10 min. Complete retrieval of the cytobrush contents was performed by three consecutive washings in 500 l of RLT-␤-ME buffer. The samples were then centrifuged Ն10,000 rpm. The clear lysate was then retrieved to which 70% ethanol was added and transferred to the RNeasy spin column. Subsequent steps were then performed according to the manufacturer's recommendation. Genomic DNA contamination was removed by incubating the sample using RQ DNase (Promega) at 37°C for 1 h. The RNA concentration and quality were analyzed using Nanodrop 8000 Spectrophotometer (Thermo Fisher Scientific). RNA integrity was evaluated using Agilent 2100 Bioanalyzer with RNA 6000 Nano LabChip Kit (Agilent Technologies). The ribosomal RNA ratio (28S to 18S) of the RNA samples was between 1.9 and 2.1 and the RNA integrity number was between 7.5 and 8. 4 .
RNA amplification from endometrial biopsies. RNA amplification, cDNA synthesis, labeling, and hybridization were performed according to GeneChip expression analysis technical manual (P/N 702232). Briefly, two cycles eukaryotic target labeling assay was performed using 100 ng of total RNA as a starting material. After cDNA synthesis in the first cycle, an unlabeled ribonucleotide mix was used in the first cycle of in vitro transcription (IVT) and amplification reaction. The IVT and RNA amplification were performed using MEGAscript T7 Kit (Applied Biosystems, Foster City, CA) at 37°C for 16 h. Unlabeled cRNA was purified using GeneChip IVT cRNA cleanup kit (Affymetrix) and reverse transcribed in the first-strand cDNA synthesis step of the second cycle using random hexamer primers. Subsequently, the T7-Oligo (dT) promoter primer was used in the second-strand cDNA synthesis to generate double-stranded cDNA template containing T7 promoter sequences. The resulting double-stranded cDNA was then in vitro transcribed, amplified, and labeled using a biotinylated nucleotide analog/ribonucleotide mix in the second IVT reaction using GeneChip IVT labeling kit (Affymetrix). The biotin-labeled cRNA was fragmented and analyzed using a Agilent 2100 Bioanalyzer with RNA 6000 Nano LabChip Kit (Agilent Technologies). Eukaryotic poly-A RNA control kit was used as a SPIKE-IN control to monitor the entire target labeling process, The controls are then amplified and labeled together with the samples as each eukaryotic GeneChip probe array contains probe sets for several Bacillus subtilis genes (lys, phe, thr, and dap) that are absent in eukaryotic samples.
Affymetrix array hybridization. The GeneChip Bovine Genome Array (Affymetrix) was used for hybridization. For this, a hybridization cocktail consisting of fragmented and labeled cRNA, control oligonucleotide B2 (3 nM), 20ϫ eukaryotic hybridization controls (bioB, bioC, bioD, cre) (Affymetrix), 2ϫ hybridization mix, DMSO, and RNase-free water were mixed to a final volume of 200 l. The mix was then heated at 99°C for 5 min followed by 5 min incubation at 45°C. The samples were then hybridized to GeneChip Bovine Genome Array consisting of 24,128 probe sets. Hybridization was performed for 16 h. Three biotin-labeled cRNA hybridizations were performed for endometrial samples of each category (CDd7, CDd14, NPd7, and NPd14).
Affymetrix array washing, staining, and scanning. The probe arrays were washed and stained using the Fluidics Station 450/250 (Affymetrix) and scanned using the GeneChip3000 laser confocal slide scanner (Affymetrix) integrated with GeneChip Operating System as recommended in GeneChip expression wash, stain, and scan user manual (P/N 702731).
Affymetrix data analysis. The microarray data normalization and background correction was performed using guanine cytosine robust multiarray analysis (GCRMA) (71) . For this, we used R software, (http://www.r-project.org) and Bioconductor packages (http://www. bioconductor.org). During normalization, the CEL files were first converted into expression set using the GCRMA considering probe sequence and the GC-content background correction. Starting with the probe-level data from a set of GeneChips, the perfect-match values were background-corrected, normalized, and finally summarized resulting in a set of expression measures. The raw and normalized data are available at Gene Expression Omnibus (GEO), http://www.ncbi. nlm.nih.gov/geo/ with accession number GSE21049 or GSE20974. The intensity distribution and uniformities between the arrays were evaluated by assessing Pearson correlation and heat map, MA plots, and density plots (Supplemental Fig. S1 ).
1 Differentially expressed (DE) genes were obtained using linear models for microarray data (LIMMA), which requires two matrices, namely the design matrix, which provides a representation of the different RNA targets that have been hybridized to the arrays, and the contrast matrix, which allows the coefficients defined by the design matrix to be combined into contrasts of interest (58) . P values were adjusted using the BenjaminiHochberg procedure that controls the false discovery rate (FDR) (8) . Differentially expressed genes were further classified according to their gene ontology (GO) of molecular functions and biological processes using GO statistical analyses (GOstats) (18) . Moreover, molecular pathways participated by DE genes were identified from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http:// www.genome.jp/kegg/).
RNA isolation and cDNA synthesis from embryo biopsies. Total RNA was extracted from 15 embryos that resulted in calf delivery or no pregnancy in three pools each consisting of five embryos using PicoPure RNA isolation kit (ARCTURS). On column DNA digestion was performed to remove DNA contamination of RNA samples using RNase-Free DNase (Qiagen).
RNA amplification from embryo biopsies. First-strand cDNA was synthesized from total RNA samples of embryos resulting in calf delivery and no pregnancy group using T7 promoter attached oligo (dT)21, superscript reverse transcriptase II (Invitrogen) and random hexamers as described previously (15, 17, 20) . Second-strand cDNA was then synthesized using degenerated oligonucleotide primer-PCR master kit (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's recommendation. The resulting double-strand cDNA was purified and in vitro transcribed using AmpliScribe T7 transcription kit (Epicentre Technologies). The amplified RNA (aRNA) was purified using RNeasy Mini kit (Qiagen, Hilden, Germany) and eluted in RNase free water. The RNA concentration and quality were analyzed using Nanodrop 8000 Spectrophotometer (Thermo Fisher Scientific).
Microarray hybridization using embryo biopsies. Minimum information about microarray experiments guidelines (11) was adhered to the experimental design. We used 3 g of aRNA from embryos resulting in calf delivery or no pregnancy as a template in reverse transcription reactions. Amino-modified dUTPs were incorporated into the cDNA using the cyscribe postlabeling kit (Amersham Biosciences, Freiburg, Germany). The purified aminoallyl-labeled cDNA samples derived from embryos resulting in calf delivery were then labeled with N-hydroxysuccinate-derived Cy5 dye, and those samples of embryo resulting in no pregnancy were labeled with Cy3 dye using the cyscribe postlabeling kit (Amersham Biosciences). To avoid variation due to dye coupling, aminoallyl-labeled cDNA samples of the calf delivery group were labeled with Cy3 and no pregnancy groups were labeled with Cy5 dyes. The dye-labeled samples were then incubated for 15 min at room temperature in the dark. At the end of incubation, nonreacting dyes were quenched by addition of 15 l of 4 M hydroxylamine solution (Sigma-Aldrich) and incubated for 15 min at room temperature in the dark. The reaction was then purified with CyScribe GFX Purification kit (Amersham Biosciences) and finally eluted in 60 l elution buffer.
Target clones. The ready-made bovine cDNA array (BlueChip version 3, kindly provided by Prof. Marc-André Sirard, Laval University, Quebec, Canada) was used for hybridization. The BlueChip array consisting of Ͼ3,000 probe sets (6,766 spots) and ϳ2,300 targets genes derived from subtraction suppressive hybridization of bovine embryo and tissues. In addition to the target probe sets, the BlueChip array consists of control clones including alien1 (530 spots), alien2 (540 spots), GFP (4 spots), Doublets (96), GFP (348 spots), GFP1/2 (30 spots), GFP1 (30 spots), GFP1/4 (6 spots), GFP1/8 (6 spots), GFP1/16 (6 spots), and H 2O/DMSO (380), Negative (6 spots), plant (540 spots), vide (96 spots), tubulin (8 spots), ubiquitin (8 spots), and actin (12 spots).
Probe preparation and hybridization. Before hybridization, the arrayed slides were placed in a Corning GAPS II slide container containing 50 ml prehybridization buffer [0.5 g bovine serum albumin (BSA, Roche Diagnostics) ϩ 0.5 ml 10% SDS ϩ 7.5 ml 20% SSC ϩ 42 ml sterile water] and incubated for 20 min at 55°C. After the end of incubation, the slides were sequentially washed with boiled water, cold water, and isopropanol followed by centrifugation at 2,000 rpm for 2 min. Immediately before hybridization, dye-labeled probes were dissolved in 55 l formamid-based buffer (15 l hybridization buffer ϩ 30 l 100% formamid ϩ 10 l distilled water) to which 2.5 l yeast tRNA and 2.5 l human cot-DNA (Invitrogen) were added to avoid non specific hybridization. After being denatured at 95°C for 5 min, the mix was hybridized to the array and covered with coverslips (ROTH, Karlsruhe, Germany). A total of six hybridizations (three biological and three technical replicates as dye swap) were carried out between the two sample groups. The hybridized array slide was then placed in the hybridization chamber (GFL, Dülmen, Germany) and incubated at 42°C for 20 h in the dark. At the end of the incubation, the slides were sequentially washed for 10 min with 2ϫ SSC plus 0.1% SDS, 5 min each with 0.2ϫ SSC and 0.1% SSC buffers, 1 min each with water and isopropanol, and centrifuged at 2,000 rpm for 2 min.
Image capture and array data analysis. Microarray scanning and image analysis of he cDNA array was performed using Axon GenePix 4000B scanner and GenePix Pro analysis software (version 4.0) (Axon Instruments, Foster City, CA), respectively. The normal expression and offset method was used to correct the background (53) . LOESS normalization was applied to normalize within array variations (59, 72) , and scale normalization was used to normalize differences between arrays due to changes in the photomultiplier tube setting of the scanner. A mean log2 transformed value of (Cy5/Cy3) was calculated from three replicates to obtain one value per clone. The raw and normalized data are available at GEO (http://www.ncbi.nlm. nih.gov/geo/) with accession number GSE21047 or GSE21049. Differentially expressed genes were obtained using LIMMA (58) . Those genes whose average expression value Ͼ1.5-fold change and P Ͻ 0.05 were considered as DE genes. The heat map of DE genes was drawn using the heat map function of Bioconductor.
Quantitative real-time polymerase chain reaction. The minimum information for publication of quantitative real-time PCR experiments (MIQE) guidelines were employed during measuring gene expression level using quantitative real-time PCR (12) . According to the guideline, qPCR was used as abbreviation of quantitative real-time PCR through the text. In the current study qPCR was used to validate the DE genes and to quantify some candidate genes across the estrous cycle. For this sequence specific primers (Supplemental Tables S1 and S2) were designed using primer express v. 2.0 (Applied Biosystems). Specificity of the PCR amplification was validated by sequencing the PCR product using CEQ 8000 Genetic Analysis (Beckman Coulter, Krefeld, Germany). Following this, the cDNA samples used for qPCR were synthesized by reverse transcription of total RNA endometrial and embryo biopsy samples as described previously in our laboratory (15, 17, 20) . Prior to qPCR, the concentration of the cDNA samples from each treatment group was determined using the Nanodrop 8000 Spectrophotometer (Biotechnology, Erlangen, Germany). Similar amount of cDNA samples were used to compare samples from different treatment groups. The qPCR was performed in 20 l reaction volume containing iTaq SYBR Green Supermix with ROX (Bio-Rad Laboratories, Munich, Germany), the cDNA samples, and the specific forward and reverse primer in ABI PRISM 7000 sequence detection system (Applied Biosystems). The qPCR thermal cycling parameter was set as 95°C for 3 min, 40 cycles of 15 s at 95°C, and 45 s at 60°C. At the end of the qPCR reaction, the specificity of amplification for each gene was evaluated by monitoring the dissociation (melting) curve. Transcript abundance of the samples was determined using the relative standard curve method using a serial dilution of 10 1 -10 9 copy numbers prepared from plasmid DNA. The data generated was considered for further analysis provided that the slope and the regression line (R 2 ) of the standard curve were between (Ϫ3.2 to Ϫ3.6) and Ն0.99, respectively. Following this, the copy numbers of the target genes were normalized against the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The expression of GAPDH was not significantly different between the samples to be compared. The normal distribution was tested by the Kolmogorow-Smirnov method and those skewed expression values were log2 transformed prior to statistical analysis. The Student's t-test or least significant difference test procedures of SAS version 9.2 (SAS Institute, Cary, NC) was used to determine mRNA differences between the samples. Differences with P Ͻ 0.05 were considered significant.
Expression profile of candidate genes during the estrous cycle and early pregnancy. Following identification of DE genes between the receptive and nonreceptive endometrium, we examined the expression pattern of some candidate genes at different phases of the estrous cycle and early gestation period using the endometrial samples collected from 18 normal cyclic heifers slaughtered at days 0, 3, 7, 14 , and 19 of the estrous cycle and three pregnant heifers slaughtered at day 50 pregnancy period. For this, we selected randomly six candidate genes among those whose expression was increased in receptive endometrium [interferon regulatory factor 6 (IRF6), prostaglandin E receptor 4 (PTGER4), inositol 1,4,5-trisphosphate receptor type 1 (ITPR1), adenosine A2B receptor (ADORA2B), prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase, PTGS2/COX-2), tissue inhibitor of metalloproteinase 3 (TIMP3)] and three other genes whose expression was increased in nonreceptive endometrium [signal transducer and activator of transcription 5A (STAT5A), matrix metalloproteinase 2 (MMP2) and angiotensin II receptor, type 1 (AGTR1)]. This was aimed at evaluating the pattern of those differentially expressed genes at different stage of the estrous cycle and to assess whether the genes increased or reduced in receptive endometrium during the estrous cycle will continue or decay during early gestation period. For this, 18 animals were slaughtered during of estrous cycle following standard synchronization protocol and three animals were slaughtered at day 50 of the gestation period. Endometrial samples were collected from seven different positions of the uterus by scraping, namely ipsilateral cranial, ipsilateral middle, ipsilateral caudal, contra lateral cranial, contralateral middle, contralateral caudal, and corpus (5) .
Immunohistochemical localization of candidate genes during the estrous cycle and early pregnancy. The protein expressions of IRF6, ITPR1, PTGS2, and MMP2 were localized in the ipsilateral middle part of the uterine tissue section. For this, the sections were washed in PBS and fixed in 4% (wt/vol) paraformaldehyde overnight at 4°C. The fixed specimens were permeabilized in 0.5% (vol/vol) Triton-X100 (Sigma) in PBS and blocked in 3% (wt/vol) BSA (Roche Diagnostics) in PBS. The samples were incubated overnight using rabbit polyclonal primary antibody specific IRF6, ITPR1, PTGS2, or MMP2. Rabbit polyclonal primary antibody (Santa Cruz Biotechnologies, Santa Cruz, CA) against IRF6 and PTGS2 was diluted at 1:100 PBS and rabbit polyclonal primary antibody against ITPR1 and MMP2 (Lifespan Biosciences) at 1:50 in blocking solution. Fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit secondary antibody (Lifespan Biosciences) diluted at 1:100 in PBS used in all cases. Counterstaining was performed using 4=,6=-diamidino-2-phenylindole hydrochloride (Burlingame, CA). After the final wash in PBS, the sections were mounted on glass slides and visualized on an ApoTome microscope (Carl Zeiss MicroImaging).
RESULTS

Pretransfer gene expression of receptive and nonreceptive endometrium.
To investigate whether the pattern of endometrial gene expression during the estrous cycle influences the pregnancy outcome, endometrial samples were collected one cycle prior to embryo transfer during days 7 and 14 of the estrous cycle. Embryo biopsies were transferred to 54 Simmental heifers in the next estrous cycle. From those, 39% transfers returned to heat at day 21 and those heifers were designated as no pregnancy group or nonreceptive endometrium (NP). The remaining 41% were pregnant until day 56, and 27% of the transfers ended up with successful calf deliv- ery. Heifers with successful pregnancies and calf deliveries were designated as the calf delivery group or receptive endometrium (CD). For insight into the transcriptome events in receptive and nonreceptive endometrium during the pretransfer period, endometrial gene expression was determined from both endometrium groups at day 7 and day 14 of the estrous cycle using the endometrial biopsy and the pregnancy outcome information.
The gene expression profile in receptive (CDd7) and nonreceptive endometrium (NPd7) at day 7 of the estrous was established using endometrial biopsies taken at day 7 the estrous cycle from calf delivery groups and no-pregnancy groups, respectively. Hence, using the GeneChip Bovine Genome array, representing Ͼ23,000 bovine transcripts, we identified 1,126 DE genes (P Ͻ 0.05 and fold Ն2, FDR Յ0.27) between CDd7 and NPd7 (Fig. 2) . Among those, 612 genes were more abundantly expressed in receptive (CDd7) and 514 were abundant in nonreceptive (NPd7) endometrium. The top abundantly expressed genes in CDd7 compared with NPd7 include CDC20, GCLC, PLLP, COL4A4, TMEM163, LOC510320, MTTP, NETO2, CDC2, COX6B2, and PPP2R5A. On the other hand, those highly expressed in nonreceptive endometrium (NPd7) compared with CDd7 include HOXA9, COL1A2, NTRK2, COL3A1, GJA1, COL21A1, LHFP, IGJ, SPOP, OGN, COL6A1, and SPARC. The first 300 DE genes are described in Supplemental Table S3 . In addition, the DE genes included several gene clusters whose expression was elevated either in CDd7 or NPd7. Among those, the expression levels of solute carrier cluster, cell division cycle clusters, adaptor-related protein complex, kinesin clusters, leucine-rich repeats, coiled domains, ATPases, protein kinases and phosphatase clusters, transmembrane proteins, junctional adhesion molecules, and integrins were higher in CDd7 (Fig. 3) . On the other hand, the expression levels of cluster of differentiation (CD) molecules, chemokine molecules, homeobox genes, collagen families, S100 calcium binding protein, and zinc finger proteins were increased in NPd7 (Fig. 4) .
To obtain an overview of transcriptome functional changes that have been occurred in CDd7 and NPd7, GO enrichment analysis was performed using GOstats. Several biological process categories including macromolecule localization, protein and cellular localization, posttranscriptional modification, signal transduction, antiapoptosis, and cell cycle were overrepresented in genes elevated in CDd7 (Figs. 5 and 6 ). On the other hand, cellular metabolic processes, response to stimuli, immune response, induction of apoptosis, and chemokine activity were among the biological process or molecular functions overrepresented in NPd7 groups (Figs. 7 and 8, A-C) . Along with their biological process, the DE genes were classified according to molecular functions that describe their activities at the molecular level. Thus, numerous molecular functions including transferase activity, transmembrane transport, metal peptidase activities, symporter activity, and kinase activity were overrepresented in DE genes that were abundantly expressed in CDd7 (Fig. 9A, Supplemental Fig. S2 ). On the other hand, protein binding activity, transcription factor activity, chemokine activity, and extracellular matrix (ECM) remodel- ing were among the main molecular function overrepresented by genes that were elevated in NPd7 (Figs. 9B and 8, D and E) .
Along with gene enrichment analysis, the most important pathways in which DE genes participated were identified from the KEGG database. From this analysis, 25 molecular pathways involving in signaling and metabolic activities were identified (Table 1) . Interestingly, molecular pathways including the tight junction, integrin signaling, inositol phosphate metabolism, calcium signaling pathway, focal adhesion, apoptosis, GnRH, VEGFB ,and PPAR signaling pathways were dominated by DE genes increased in CDd7. On the other hand, T cell receptor pathway, cytokine-cytokine receptor, p53 signaling pathway, and focal adhesion pathways were dominated by DE genes whose expression was increased in NPd7.
Investigation of the pretransfer gene expression difference between receptive endometrium (CDd14) and nonreceptive endometrium (NPd14) revealed that differential expression of only 14 genes [including 5 expressed sequence tags (ESTs)] (Fig. 10) . Among those, the expression of C20ORF54 and FZD8 was higher in CDd14, while the expression of LOC786821, BRWD1, ANKRD11, SLC25A12, GJA1, SCARA5, IIGLL1, and other 5 ESTs was higher in NPd14. From those, GJA1 and SCARA5 were among the DE genes increased in nonreceptive endometrium (NPd7) during day 7 of the estrous cycle. However, the number of genes that were DE in CDd14 vs. NPd14 was significantly lower compared with the number of DE genes between CDd7 vs. NPd7, where 1,126 genes were DE (Fig. 2) . This numeric difference indicates that endometrium that result in calf delivery and endometrium result in no pregnancy are molecularly distinguishable during day 7 than day 14 of the estrous cycle.
Transcriptome dynamics of receptive and nonreceptive endometrium. To identify genes that are elevated or decreased in their expression as the receptive endometrium proceeds from day 7 to day 14 of the estrous cycle, we compared the transcriptome profile of CDd7 and CDd14. The result indicated that from 17,368 detected transcripts both in CDd7 and CDd14, 1,867 genes were DE between the two groups. Of these, the transcript levels of 1,014 genes were higher in CDd7 and the transcript level of 853 were increased in CDd14 (Fig. 11 , Supplemental Table S4 ). The genes, including DGKI, EDN3, SVS8, SPC24, PRODH, PDZK1, PLLP, CCNB1, LPL, and GDPD1, exhibited a higher fold increase (54-to 397-fold) in CDd7, but the transcript levels of SLC39A2, DEFB1, TINAGL1, C15H11ORF34, LOC286871, IL8, GPLD1, LYZ1, and IGFBP1 were higher (45-to 418-fold) in CDd14. This indicated the extent of temporal degradation or induction of genes in receptive endometrium as the endometrium proceeds from day 7 to day 14 of the estrous cycle. To gain a better insight into the functional contribution of these genes, overrepresentation of gene sets defined by biological process of GO was tested. Those genes that are abundant in CDd7 were found to be involved in various biological processes, including cellular material transport, metabolic process, protein modification, phosphorylation, and posttranslational protein modification. On the other hand, immune responses, apoptotic process, and signal transductions were among the main biological processes in those genes whose transcript level was increased in CDd14 (Supplemental Fig. S3) . Moreover, the differentially expressed genes were found to be participated in 21 molecular pathways (Table 2) , among which the MAPK signaling pathway, Toll-like receptor signaling pathway, adipocytokine signaling pathway, cell adhesion molecules and ECM receptor interaction pathways were dominated by those with genes whose expression levels was higher in CDd14. This shows that the receptive endometrium exhibits distinct and unique biological processes and molecular functions as it proceeds from day 7 to day 14 of the estrous cycle.
Similar to receptive endometrium, the transcriptome dynamics of nonreceptive endometrium was evaluated by comparing the gene expression of NPd7 and NPd14. The result revealed that from 17,361 detected transcripts in NPd7 and NPd14, 254 genes were DE between the two groups (Fig. 12 , Supplemental Table S5 ). Compared with the number of DE genes in CDd7 Fig. 7 . Overrepresentation of gene sets defined by the biological process of GO for genes whose transcript level was decreased in receptive endometrium (CDd7), compared with nonreceptive endometrium NPd7 at day 7 of the estrous cycle. vs. CDd14, the number of genes that were DE in NPd7 vs. NPd14 was significantly lower by 1,613 genes, indicating higher differences in the rate of induction or degradation of transcripts in receptive compared with the nonreceptive endometrium as the estrous cycle proceeds from days 7 to 14 of the estrous cycle. Several genes including DGKI, SVS8, SPC24, SPOP, COL6A1, TXNDC6, NTRK2, APOD, PRUNE2, SD17B13, and COL6A3 were the topmost DE genes with higher transcript level in NPd7, and PLEK, FMNL3, TLN2, NPNT, SPP1, SDS, IL8, SLC39A2, ISG15 were among the topmost genes whose expression level was increased in NPd14.
Expression profile of some candidate genes during the estrous cycle and early pregnancy. Following identification of DE genes between the receptive and nonreceptive endometrium, the expression pattern of some candidate genes was evaluated at the different phases of the estrous cycle and early gestation. The genes include those involved in transcriptional factor activity (IRF6, STAT5A), signal transduction (PTGER4, AGTR1, ITPR1, ADORA2B), metalloendopeptidase activity (MMP2, TIMP3), and prostaglandin-endoperoxide synthase activity (PTGS2 or COX-2). The expression profile of those genes across the estrous cycle and early gestation period indicates that IRF6, ITPR1, STAT5A, and AGTR1 exhibited an increased trend from proestrus to diestrus and reached a peak in pregnant endometrium (Fig. 13) , whereas the expression level of PTGER4, PTGS2/COX-2, TIMP3, and ADORAB2B was reduced in pregnant endometrium compared with day 7 and 14 of the estrous cycle. In addition, the immunohistochemical localization of IRF6, ITPR1, PTGS2, and MMP2 proteins in the tissue sections of the ipsilateral middle part of the uterus revealed the presence of spatiotemporal differences in protein signal intensities of those genes during the estrous cycle and early pregnancy (Fig. 14) . This shows that those genes exhibiting higher or lower expression level during the estrous cycle can be further enhanced or reduced following embryo implantation.
Gene expression in embryo biopsies that resulted in calf delivery and no pregnancy. Using preimplantation embryospecific cDNA array and embryo biopsy techniques, we have determined the gene expression difference between embryos that resulted in calf delivery and those resulting in no pregnancy. The microarray data analysis revealed that a total of 70 DE genes between those two groups of embryo (Fig. 14) . The transcript level of 32 genes including SPAG17, PF6, UBE2D3P, DFNB31, AMD1, DTNBP1, and ARL8B was abundant in those embryos resulting in calf delivery (Fig. 15) . On the other hand, the transcript level of 38 genes including RYBP, RNF34, KPNA4, and WDR13 was higher in embryos resulting in no pregnancy. This differences indicated that the embryos that resulted in calf delivery are molecularly distinguishable from those resulting in no pregnancy. Moreover, those genes were found to be participated in developmentally important biological and molecular functions (Supplemental Table S6 ) including gene expression (EEF1A1, ZNF638, SFMBT1, RPL7A, RBMX), cell signaling and cell communication (STYL, GBF1, CCL16, DTX2, RALA, GNB2L1, MS4A8B), transport of macromolecules (KPN4, NUP35, SGK1, FBP5, STX8, KIF20A, P2B1), regulation of transcription (RYBP, LEO1, ZNF207, ZNF83, ZNF207, FADS1), apoptosis (RYBP, NUDT2, SGK1, RNF34), physiological response to stimulus (DFNB31, DTNBP1, HSA8, UBE2N), transferase activity (AP2B1, SGK1, GART, PTDSS1), and chemokine activity (CCL16). However, the numbers of DE genes and molecular signatures derived from comparing the embryo biopsies resulting in successful calf delivery and no pregnancy were by far fewer compared with the DE genes obtained from comparing the endometrial biopsies resulting in calf delivery and no pregnancy. This doesn't imply that the endometrium or the maternal environment is more important than the embryo during embryo pregnancy establishment. However, this was indeed related to differences in the microarray platform used.
Validation of microarray data using real-time qPCR. To validate our microarray results, the expression level of 36 DE genes between receptive and nonreceptive endometrium (CDd7 vs. NPd7) was evaluated by qPCR using four independent cDNA samples of CDd7 or NPd7 in three technical replicates. The qPCR confirmed 32 from 36 genes (Table 3) . Complete list of the confirmation result is described in Supplemental Fig. S4 . In addition, eight DE genes between embryo biopsies resulting in calf delivery and no pregnancy were measured with qPCR, and the microarray data were found to be consistent with the qPCR data ( Table 4) .
DISCUSSION
The dynamic interaction between the embryo and maternal environment can be stimulated provided both the endometrium and embryos are enriched with key molecular mediators and signaling pathways at the time of arrival of the embryo in the uterus. Thus, understanding the molecular changes that occur in endometrium and embryo during the time of embryo transfer is fundamental to understand the molecular mechanisms re- Molecular pathways containing genes with the highest mRNA levels in CDd7 (boldface) and genes with the highest mRNA levels in NPd7 (lightface). lated to the establishment of pregnancy by assisted reproduction technology. Therefore, in the present study we established a direct connection between the bovine pretransfer endometrial and embryo gene expression and the upcoming pregnancy outcome using endometrial and embryo biopsy techniques. This was aimed at identifying the maternal and embryonic genes that could presumably related to pregnancy success. Accordingly, noticeable endometrial gene expression differences were shown at day 7 of the estrous cycle between heifers that delivered calves (with receptive endometrium) and those that had no pregnancy (with nonreceptive endometrium). We have applied a detailed bioinformatics and literature-mining approach to characterize those DE genes with respect to bovine endometrial receptivity and embryo implantation. The KEGG and GO enrichment analysis of biological processes and molecular functions showed the presence of transcriptomic functional alteration between receptive and nonreceptive endometrium at day 7 of the estrous cycle. However, two groups of the endometrium tended to exhibit minimum difference in gene expression profile day 14 of the estrous cycle. This may be Table 2 . Molecular pathways containing genes with the highest mRNA levels in CDd7 (boldface) and genes with the highest mRNA levels in CDd14 (lightface). A: the number and fold change distribution of DE genes in CDd7 vs. CDd14. B: the heat map representing the expression pattern of DE genes between CDd7 and CDd14. CDd7_1, CDd7_2, and CDd7_3 represent independent biological replicates from receptive endometrium groups at day 7 of the estrous cycle. CDd14_1, CDd14_2, and CDd14_3 represent independent biological replicates from receptive endometrium groups during day 14 of the estrous. Red and green colors reflect the high and low expression, respectively.
attributed to the degree of endometrial response to the circulating progesterone. The progressively increasing level of progestrone may induce the expression of two sets of genes in receptive endometrium: one set of those genes triggered in the expectation of an embryo and the second group associated with induction of follicular waves. Therefore, unlike the nonreceptive endometrium, at day 7 of the estrous cycle the receptive endometrium may be enriched with several molecules related to the establishment of pregnancy. However, from day 14 onward, the progesterone that regulates the uterine environment loses its ability to block formation of oxytocin (55) . The endometrial PGF 2 ␣ then starts to increase on day 14 and reaches its peak from day 15 to day 17 of the estrous cycle (56) . Therefore, those groups of genes that were induced or reduced in receptive endometrium during day 7 of the estrous may gradually decline during day 14 of the estrous cycle. This may consequently result in little or no gene expression differences between receptive and nonreceptive endometrium at day 14 of the estrous cycle. Thus, this result may suggest that the receptive and nonreceptive endometrium can be molecularly more distinguishable at day 7 than day 14 of the estrous cycle. Since receptive and nonreceptive endometrium were molecularly more distinguishable at day 7 than day 14 of the estrous cycle, in the present study we focused on the transcriptome difference exhibited at day 7 of the estrous cycle.
Once the embryo reaches the uterus for implantation, the molecular dialogue between the implanting conceptus and the endometrium is mediated by several molecules of endometrial and/or embryo origin (16, 50, 61, 68, 70) . Identifying those molecules in endometrium and embryo prior to transfer may help to select receptive endometrium and embryos with higher implantation potential. In line with this, in the present study Ͼ1,100 genes consisting of several gene clusters were DE between the receptive and nonreceptive endometrium at day 7 of the estrous cycle (Figs. 2-4 , Supplemental Table S1 ). This may suggest the occurrence of different molecular events in the endometrium whose expression is either induced or turned off in the expectation of blastocyst arrival into the uterus. For instance, 19 solute carrier (SLC) genes (Fig. 3) were among the gene clusters increased in receptive endometrium. The SLC genes are believed to be involved in transport of cellular materials across the cell membrane (32, 34, 45, 49) . In addition, several transmembrane proteins and the voltage-dependent anion channel 1 (VDAC1) that are related to cellular material transport (1, 2) were also found to be abundant in receptive endometrium. This may suggest the presence of effective metabolite exchange between mitochondria and cytoplasm in receptive endometrium compared with nonreceptive endometrium.
In addition to those listed above, the transcript level of adapter-related protein and their subunits (AP1-S1, AP3-B1, AP3-M1, and AP3-S2) was higher in the receptive compared with the nonreceptive endometrium. The adapter-related proteins are involved in protein and cellular transport (Fig. 6 , A-C) and in protein cargo sorting, integral membrane proteins trafficking, and lysosome-related organelle formation (10, 47) . Therefore, increased level of adapter-related proteins in receptive endometrium and the corresponding decrease in nonreceptive endometrium may be associated with accumulation and transduction of energy and increase in the number of lysosomes that could be required for uterine receptivity and embryo implantation. However, for this to be effective the endometrial cells should increase in size and number through proliferation. Interestingly, in the current study, the antiapoptosis genes associated with cell proliferation (BCL2, VEGFB, EDN1, MYB, CDC2, BIRC5, VDAC1, and GCLC) were elevated in receptive endometrium (Fig. 6E) , but the proapoptotic genes associated with cell death (PRKRA, CASP4, PYCARD, LCK, TP53I3/PIG3, and MYC) were higher in nonreceptive endometrium (Fig. 8B) . Similar studies (14, 23, 62) have also indicated the importance of antiapoptotic gene BCL-2 for the survival of endometrial glandular cells and endothelin-1 (EDN1) in regulation of the conceptus and endometrium at the time of implantation. Therefore, proapoptotic genes may influence the endometrial receptivity and implantation by facilitating cell death and inhibiting cell proliferation, ultimately leading to loss of endometrial epithelial cells. Hence, enrichment of antiapoptotic genes and reduced level of proapoptotic genes in receptive endometrium may suggest faster cellular proliferation and differentiation to prepare the endometrium for substantial remodeling.
The high rate of early embryonic mortality in cattle and other animals may be a maternal immunological attack against conceptus antigens of paternal origin (64) . Therefore, reduced level of immune response of the maternal environment may be required to maintain the conceptus during the entire gestation period. In the present study, cluster of differentiation (CD) molecules (CD247/CD3Z, CD36, CD8A, CD8B), chemokine molecules (XCL1, CCL28, CXCL2, CXCL12, CXCL5) (Fig.  3) , and several genes related to the immune system (CSF3, IL18, BOLA-NC1, TNFSF13, CFD/DF) were found to be reduced in receptive compared with nonreceptive endometrium. The involvements of CD and chemokine molecules in immune system have been described several authors (51, 67, 69) . This may suggest that the receptive endometrium can adjust the immune system to create conducive environment for immune tolerance of the incoming embryo.
The collagens, tissue inhibitors of matrix metalloproteinase (TIMP), and MMP are among the main components of ECM, and their abnormal expression may be associated with implantation defects. Our results indicated that the expression of collagens (Figs. 4, 8E) , the MMP2 and TIMP1 was reduced, but TIMP3 was abundantly expressed in receptive compared with nonreceptive endometrium. Similar to our results, COL1A1, COL1A2, and COL6A1 were reported to be higher in nonpregnant compared with pregnant cow (6) and higher mRNA levels of TIMP1 and MMP2 were reported to be associated with unexplained infertility and/or recurrent miscarriages in humans (33) .
Junctional adhesion, gap junction, or connexin expression is thought to be a biological marker for endometrial receptivity in human (26) . In our results, the mRNA level of junctional adhesion molecules 2 and 3 (JAM2/JAMB and JAM3/JAM-C) was found to be increased in receptive compared with the nonreceptive endometrium. The higher expression of JAM3/ JAM-C can be associated with increased in the number of uterine natural killer cells that are required to enhance blood flow to the implantation site, which may be required in the development of the placenta during implantation (27) (28) (29) . Moreover, those genes are believed to enhance cell-to-cell adhesion and control the flow of solutes and water between cells of epithelium (3, 4, 65) . Similarly, among the gap junctional proteins, gap junction protein beta 5 (GJB5) or connexin-31 (CX31.1) and gap junction protein beta 6 (GJB6) or connexin-30 (CX30) were elevated, but gap junction protein alpha-1 or connexin 43 (GJA1/CX43) was reduced in receptive compared with nonreceptive endometrium. Among these, GJB5/CX31.1 is required for normal placental development (73) . GJB6/CX30 is found to be abundant in late pregnant epithelium (42) . Unlike other connexins, connexin43 (GJA1/ CX43) was expressed at lower level in receptive endometrium compared with the nonreceptive endometrium. Similar to our result, the expression of CX43 was found to be reduced in the receptive phase of the endometrium. A decrease in CX43 gene expression in endometrium at the time of implantation may be required to reduce cell-to-cell communication and to facilitate the invasion of trophectoderm through the stroma cells (25) . This suggests that a low level of CX43 is required during the receptive period of the endometrium.
Other families of cell adhesion molecules that were increased in receptive compared with nonreceptive endometrium are the alpha integrin 2 (ITGA2) and alpha 6 integrin (ITGA6). Similar reports in humans have shown increased expression of ITGA2 and ITGA6 during the window of implantation (9, 38) . Moreover, the upregulation of ITGA6 expression was speculated to be related to its involvement in the attachment of cells to the ECM and induction of cell migration and invasion (66). Therefore, the increased level of these integrin in receptive endometrium compared with nonreceptive endometrium may suggest the importance of appropriate integrin expression for establishment of uterine receptivity and embryo implantation.
Once we have determined the DE genes between the receptive and nonreceptive endometrium, we have also addressed the diestrus transcriptome dynamics of receptive or receptive endometrium between days 7 and 14 of the estrous cycle. Results of the present study revealed that the mRNA dynamics (degradation or induction) between days 7 and 14 of the estrous cycle to be seven times higher in receptive endometrium than the nonreceptive endometrium showing higher dynamic changes in mRNA profile in receptive endometrium. This can be related to the fact that nonreceptive endometrium has few or no genes can alter their expression to support the incoming embryo at any stage of the estrus cycle. However, in receptive endometrium the expression level of several genes that reached peak or reduced at day 7 of the estrous cycle in the expectation of the incoming embryo alters their expression pattern at day 14 of the estrous cycle. Therefore, unlike the nonreceptive endometrium, the transcriptome abundance of those genes that are associated with endometrial receptivity can be changed at day 14 postestrus resulting in higher transcriptome abun- dance between days 7 and 14 in receptive endometrium compared with nonreceptive endometrium.
Embryo competency for implantation and uterine receptivity are two distinct processes that are equally important for successful implantation (13, 16, 68) . Thus the embryo can functions as an active unit with its own molecular program of cell growth and differentiation (13, 16) . Therefore, in the current study, in addition to endometrial gene expression, the transcriptome differences between biopsies from embryos resulting in calf delivery and from embryos resulting in no pregnancy were analyzed to generate candidate genes associated with those embryo implantation potentials. Subsequently, we have identified significantly DE genes that involve in several biological and molecular functions between the two groups of embryos (Fig. 15) . This shows that embryos that result in calf delivery can be molecularly distinguishable from embryos ending with no pregnancy. However, the number of DE genes and molecular signatures derived from comparing the two groups of embryo biopsies was by far fewer compared with the DE genes obtained from comparing the endometrial biopsies from calf-delivery and no-pregnancy embryos. This doesn't imply that the endometrium or the maternal environment is more important than the embryo during embryo pregnancy establishment. However, this was indeed related to differences in the microarray platform utilized in the two experiments.
Among the DE genes that were identified between the two embryo groups, CXCL16, AMD1, SPAG17, PF6, UBE2D3P, DFNB31, DTNBP1, and NUP35 were found to be higher in biopsies from embryos resulting in calf delivery compared with those resulting in no pregnancy. Among these, reports have also shown the importance of CXCL16 and AMD1 in cytotrophoblast invasion, placentation, cell migration, and mouse embryo development (31, 41, 48) . On the other hand, eukary- Hierarchical clustering of DE genes between embryos resulting in calf delivery and in no pregnancy. Embryo biopsies resulting in calf delivery were clustered in 1 group, while the embryo resulting in no pregnancy were clustered in the 2nd group. A, B, and C on the top of the dendrogram represent 3 biological replicates during hybridization, and D, E, and F describe the dye swap hybridization for A, B, and C replicates. Positive and negative numbers indicate genes increased in embryo biopsies resulting in calf delivery and no pregnancy groups, respectively. otic translation elongation factor 1 alpha 1 (EEF1A1) was found to be higher in embryo biopsies derived from blastocysts resulting in no pregnancy. A similar study in our laboratory (17) showed higher abundance of EEF1A1 expression in embryo biopsies derived from in vitro-produced blastocysts that resulted in no pregnancy. This shows the presence of common genes related to the progressive development of embryos derived either from in vivo or in vitro condition.
Collectively, the present data uncovered the pattern of the bovine pretransfer endometrial and embryo gene expression in relation to pregnancy establishment. To that end, endometrium that resulted in calf delivery displayed a different transcriptome profile compared with the endometrium that resulted in no pregnancy at day 7 of the estrous cycle. Those differences were accompanied by qualitative and quantitative alteration of major biological processes and molecular pathways. Along with the endometrial gene expression, the embryo that developed to term displayed different patterns of gene expression compared with those embryos failed to establish pregnancy, suggesting the potential contribution of embryo transcripts during pregnancy establishment. Therefore, our data provide a global perspective of the endometrium and embryo transcriptome in relation to the possible pregnancy outcomes. The data generated in the present study can be utilized for selecting candidate genes for further investigation aiming at developing molecular markers related to endometrial receptivity and embryo competency. However, we believe that future functional studies will be necessary to understand the key functional contribution of differentially expressed genes with respect to pregnancy success. Apart from this, in-depth investigation may be required to fully understand to what extent endometrial state can repeat itself with regard to its molecular signatures during consecutive cycles.
